ABBV

Last

$276.46

Day

+1.5%

+18.1%

+150.5%

52w

-0.9%

SPY YTD

+13.3%

Sec

—

Earnings

2026-10-3020d

EMA 21

264.86

EMA 50

259.17

EMA 200

237.71

20d high

-0.9%

5y high

-0.9%

5y range

99th

Positions held

Your positions

ABBV isn't in your positions.

Add it to see shares, cost, and P&L here.

Score

Hold

swing

Signal

Strong Buy

Target

$289.65

Stop

$263.81

Stop distance

4.6%

Target vs last

+4.8%

Bull / bear case

Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.

Bull case

ABBV is well-positioned in the pharmaceutical industry with a strong pipeline of innovative therapies that address unmet medical needs.
The stock has a strong buy recommendation with a score of 56.00, indicating positive investor sentiment.
Technical indicators show a bullish trend with the 21-day moving average above the 50-day and 200-day averages.

Bear case

The pharmaceutical industry faces intense competition, which could impact ABBV's market share and pricing power.
There are currently no quarterly trends or recent performance metrics available to support short-term growth.
Despite a strong buy signal, the stock's volatility is indicated by an ATR greater than 2%, suggesting potential risk.

Fundamentals

Market cap	—	Enterprise value	—	Trailing P/E	—	Forward P/E	—
PEG	—	Price / book	—	Beta	—	Dividend yield	—
Revenue growth	—	Earnings growth	—	Gross margin	—	Operating margin	—
Profit margin	—	ROE	—	ROA	—	Debt / equity	—
Current ratio	—	Free cash flow	—	Analyst recommendation	—	Mean target	—
52w high	—	52w low	—